BioSpace News Archive

Simulations Plus today announced the launch of version 2.0 of PKPlus, a major update to its software for analysis of preclinical and clinical trial data.

Amneal has launched isotretinoin capsules, USP, an AB-rated generic for Accutane in 10 mg, 20 mg, 30 mg and 40 mg strengths.

Chrono Therapeutics, a pioneer in digital drug therapy, today announced that Alan Levy Ph.D., CEO and chairman of the board of directors is retiring.

Zynex today announced the introduction of the NeuroMove device into its expanding direct sales force in the US market.

Aegis Sciences today launched KardiAssureTM, a first-of-its-kind urinalysis that helps healthcare providers monitor cardiovascular medication adherence in their patients.

Faxitron, a global leader in best-in-class imaging systems for medicine and life science research, today announced plans to double its North American commercial team in 2018.

The new patents extend its leadership position in development of a robust pipeline of inhibitors of Leukotriene A4 Hydrolase.

Innovative AlloSure registry brings standardization to transplant centers.

The data demonstrate that AFM13 was well-tolerated and showed promising therapeutic efficacy both in combination with the anti-PD-1 antibody Keytruda in Hodgkin lymphoma and as monotherapy in CD30-positive lymphoma.

ADM Tronics Unlimited, Inc., a technology-based developer and manufacturer of innovative technologies has authorized its subsidiary, Aurex International Corporation (“AIC”) to begin advertising its new hearing protection product, Tinnitus Shield™ in “Tinnitus Today” - the official publication of the American Tinnitus Association.